Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 11, 1996, Pages 3883-3891

  Dorin, Richard I ^a,c   Ferries, Laura M ^a   Roberts, Brian ^a   Qualls, Clifford R ^a   Veldhuis, Johannes D ^b   Lisansky, E Jonathan ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b NATIONAL SCIENCE FOUNDATION   (United States)

^c VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; METYRAPONE; NALOXONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN RELEASE; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; REGULATORY MECHANISM; STEROIDOGENESIS;

ADRENOCORTICOTROPIC HORMONE; ADULT; CORTICOTROPIN-RELEASING HORMONE; FEEDBACK; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; KINETICS; MALE; METYRAPONE; NALOXONE; PITUITARY GLAND, ANTERIOR; PITUITARY-ADRENAL SYSTEM; SEX CHARACTERISTICS;

EID: 0029798287     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.11.3883     Document Type: Article

References (46)

1. Antoni FA. 1986 Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev. 7:351-378.
2. Williams CL, Nishihara M, Thalabard JC, Grosser PM, Hotchkiss J, Knobil E. 1990 Corticotropin-releasing factor and gonadotropin-releasing hormone pulse generator activity in the rhesus monkey. Electrophysiological studies. Neuroendocrinology. 52:133-137.
3. Rivier CL, Plotsky PM. 1986 Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion. Annu Rev Physiol. 48:475-494.
4. Aguilera G, Harwood JP, Wilson JX, Morell J, Brown JH, Catt KJ. 1983 Mechanisms of action of corticotropin-releasing factor and other regulators of corticotropin release in rat pituitary cell. J Biol Chem. 285:8039-8045.
5. Orth DN. 1992 Corticotropin-releasing hormone in humans. Endocr Rev. 13:164-191.
6. Muglia L, Jacobson L, Luedke C, Majzoub JA. Regulation of the hypothamic-pituitary-adrenal axis in corticotropin-releasing hormone deficient mice Proceedings of the 77th Annual Meeting of The Endocrine Society, Washington, DC, 1995, p 256 (Abstract PI-575).
7. Veldhuis JD, Johnson ML. 1992 Deconvolution analysis of hormone data. Methods Enzymol. 210:539-575.
8. Carnes M, Lent S, Feyzi J, Hazel D. 1989 Plasma adrenocorticotropic hormone in the rat demonstrates three different rhythms within 24 h. Neuroendocrinology. 50:17-25.
9. Sarnyai Z, Veldhuis JD, Mellow NK, et al. 1995 The concordance of pulsatile ultradian release of adrenocorticotropin and cortisol in male rhesus monkeys. J Clin Endocrinol Metab. 80:54-59.
10. Veldhuis JD, Iranmanesh A, Johnson ML, Lizarralde G. 1990 Amplitude, but not frequency, modulation of adrenocorticotropin secretory bursts gives rise to the nyctohemeral rhythm of the corticotropic axis in man. J Clin Endocrinol Metab. 71:452-463.
11. Iranmanesh A, Lizarralde G, Short D, Veldhuis JD. 1990 Intensive venous sampling paradigms disclose high frequency adrenocorticotropin release episodes in normal men. J Clin Endocrinol Metab. 71:1276-1283.
12. Watanabe T, Orth DN. 1987 Detailed kinetic analysis of adrenocorticotropin secretion by dispersed rat anterior pituitary cells in a microperifusion system: effects of ovine corticotrpin-releasing factor and arginine vasopressin. Endocrinology. 121:11331145.
13. Waltman C, Blackman MR, Chrousos GP, Reimann C, Harman SM. 1991 Spontaneous and glucocorticoid-inhibited adrenocorticotropic hormone and cortisol secretion are similar in healthy young and old men. J Clin Endocrinol Metab. 73:495-502.
14. Won JG, Jap TS, Chang SC, Ching KN, Chiang BN. 1986 Evidence for a delayed, integral, and proportional phase of glucocorticoid feedback on ACTH secretion in normal human volunteers. Metabolism. 35:254-259.
15. Totani Y, Niinomi M, Takatsuki K, Oiso Y, Tomita A. 1990 Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease. J Clin Endocrinol Metab. 70:798-803.
16. DeBold CR, Jackson RV, Kamilaris TC, et al. 1989 Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man. J Clin Endocrinol Metab. 68:431-437.
17. Gomez MT, Magiakou MA, Mastorakos G, Chrousos GP. 1993 The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome. J Clin Endocrinol Metab. 77:173-177.
18. Jackson RV, Grice JE, Jackson AJ, Hockings GI. 1990 Naloxone-induced ACTH release in man is inhibited by clonidine. Clin Exp Pharmacol Physiol. 17:179-184.
19. Hockings GI, Grice JE, Walters MM, Crosbie GV, Torpy DJ, Jackson RV. 1995 A synergistic adrenocorticotropin response to naloxone and vasopressin in normal humans: evidence that naloxone stimulates endogenous corticotropin-releasing hormone. Neuroendocrinology. 61:198-206.
20. Estienne M, Kesner J, Arb B, Kraeling R, Rampacek G. 1988 On the site of action of naloxone: stimulated cortisol secretion in gilts. Life Sci. 43:161-166.
21. Rittmaster RS, Cutler Jr GB, Sobel DO, et al. 1985 Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects. J Clin Endocrinol Metab. 60:891-895.
22. Nikolarakis K, Pfeiffer A, Stalla GK, Herz A. 1987 The role of CRF in the release of ACTH by opiate agonists and antagonists in rats. Brain Res. 421:373-337.
23. Lisansky J, Peake GT, Strassman RJ, et al. 1989 Augmented pituitary corticotropin response to a threshold dosage of human corticotropin-releasing hormone in depressives pretreated with metyrapone. Arch Gen Psychiatry. 46:641-649.
24. Veldhuis JD, Iranmanesh A, Johnson ML, Lizarralde G. 1990 Twenty-four-hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretory bursts. J Clin Endocrinol Metab. 71:1616-1623.
25. Greenspan SL, Rowe JW, Maitland LA, McAloon-Dyke M, Elahi D. 1993 The pituitary-adrenal glucocorticoid response is altered by gender and disease. J Gerontol. 48:M72-M77.
26. Gumbiner B, Kelly RB. 1982 Two distinct intracellular pathways transport secretory and membrane glycoproteins to the surface of pituitary tumor cells. Cell. 58:51-59.
27. Goodman BM, Carnes M, Lent SJ. 1994 Model simulations of ACTH pulsatility. Life Sci. 54:1659-1669.
28. Veldhuis JD, Johnson ML. 1995 Specific methodological approaches to selected contemporary issues in deconvolution analysis of pulsatile neuroendocrine data. Methods Neurosci. 28:25-92.
29. Veldhuis JD, Evans WS, Johnson ML. 1995 Complicating effects of highly correlated model variables on nonlinear least-squares estimates of unique parameter values and their statistical confidence intervals: estimating basal secretion and neurohormone half-life by deconvolution analysis. Methods Neurosci. 28:130-138.
30. Widmaier EP, Dallman MF. 1984 The effects of corticotropin-releasing factor on adrenocorticotropin secretion from perifused pituitaries in vitro: rapid inhibition by glucocorticoids. Endocrinology. 115:2368-2374.
31. Jones MT, Tiptaft EM, Brush FR, Fergusson DAN, Neame RLB. 1974 Evidence for dual corticosteroid-receptor mechanisms in the feedback control of adrenocorticotrophin secretion. J Endocrinol. 60:223-233.
32. Sapolsky RM, Krey LC, McEwen BS. 1984 Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc Natl Acad Sci USA. 81:6174-6177.
33. Iranmanesh A, Lizarralde G, Johnson ML, Veldhuis JD. 1989 Circadian, ultradian, and episodic release of beta-endorphin in men, and its temporal coupling with Cortisol. J Clin Endocrinol Metab. 68:1019-1026.
34. Rivier C, Vale W. 1983 Influence of the frequency of ovine corticotropin-releasing factor administration on adrenocorticotropin and corticosterone secretion in the rat. Endocrinology. 113:1422-1426.
35. Schopohl J, Hauer A, Kaliebe T, Stalla GK, von Werder K, Muller OA. 1986 Repetitive and continuous administration of human corticotropin releasing factor to human subjects. Acta Endocrinol (Copenh). 112:157-165.
36. Desir D, Van Cauter E, Beyloos M, Bosson D, Golstein J, Copinschi G. 1986 Prolonged pulsatile administration of ovine corticotropin-releasing hormone in normal man. J Clin Endocrinol Metab. 63:1292-1299.
37. Holmes MC, Antoni FA, Catt KJ, Aguilera G. 1986 Predominant release of vasopressin vs. corticotropin-releasing factor from the isolated median eminence after adrenalectomy. Neuroendocrinology. 43:245-251.
38. Von Bardeleben U, Holsboer F, Stalla GK, Muller OA. 1985 Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. Life Sci. 37:1613-1618.
39. Muglia L, Jacobson L, Dikkes P, Majzoub JA. 1995 Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature. 373:427-432.
40. Fleischer N, Vale W. 1968 Inhibition of vasopressin-induced ACTH release from the pituitary by glucocorticoids in vitro. Endocrinology. 83:1232-1236.
41. Gaitan D, Loosen FT, Burns D, Edkhator N, Orth DN. Plasma ACTH response to naloxone in major depressive disorder (MDD), chronic alcoholism (ALC), Cushing's disease (CD) and normal subjects (NL). Proceedings of the 75th Annual Meeting of The Endocrine Society, Las Vegas, NV, 1993, p238 (Abstract 752).
42. Keller-Wood ME, Dallman MF. 1984 Corticosteroid inhibition of ACTH secretion. Endocr Rev. 5:1-24.
43. Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W. 1992 Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology. 130:3378-3386.
44. Schulte HM, Chrousos GP, Gold PW, et al. 1985 Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications. J Clin Invest. 75:1781-1785.
45. Hockings GI, Grice JE, Ward WK, Walter MM, Jensen GR, Jackson RV. 1993 Hypersensitivity of the hypothalamic-pituitary-adrenal axis to naloxone in post-traumatic stress disorder. Biol Psychiatry. 33:585-593.
46. Inder WJ, Hellemans J, Ellis MJ, Evans MJ, Livesey JH. 1995 Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes. J Clin Endocrinol Metab. 80:244-248.